abstract |
Inhibitors of the cytosolic phospholipase A2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases. The inhibitors of the present invention have the general formulawhere X, Z, R1, R2, R3, R4, Ra and Rb are as defined in the specification. |